466 related articles for article (PubMed ID: 24479687)
1. Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process.
Caudle KE; Klein TE; Hoffman JM; Muller DJ; Whirl-Carrillo M; Gong L; McDonagh EM; Sangkuhl K; Thorn CF; Schwab M; Agundez JA; Freimuth RR; Huser V; Lee MT; Iwuchukwu OF; Crews KR; Scott SA; Wadelius M; Swen JJ; Tyndale RF; Stein CM; Roden D; Relling MV; Williams MS; Johnson SG
Curr Drug Metab; 2014 Feb; 15(2):209-17. PubMed ID: 24479687
[TBL] [Abstract][Full Text] [Related]
2. CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network.
Relling MV; Klein TE
Clin Pharmacol Ther; 2011 Mar; 89(3):464-7. PubMed ID: 21270786
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group.
Bank PCD; Caudle KE; Swen JJ; Gammal RS; Whirl-Carrillo M; Klein TE; Relling MV; Guchelaar HJ
Clin Pharmacol Ther; 2018 Apr; 103(4):599-618. PubMed ID: 28994452
[TBL] [Abstract][Full Text] [Related]
4. Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines.
Pritchard D; Patel JN; Stephens LE; McLeod HL
Am J Health Syst Pharm; 2022 Jun; 79(12):993-1005. PubMed ID: 35230418
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines.
Abdullah-Koolmees H; van Keulen AM; Nijenhuis M; Deneer VHM
Front Pharmacol; 2020; 11():595219. PubMed ID: 33568995
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitous Pharmacogenomics (U-PGx): The Time for Implementation is Now. An Horizon2020 Program to Drive Pharmacogenomics into Clinical Practice.
Cecchin E; Roncato R; Guchelaar HJ; Toffoli G;
Curr Pharm Biotechnol; 2017; 18(3):204-209. PubMed ID: 28044932
[TBL] [Abstract][Full Text] [Related]
7. Variability Between Clinical Pharmacogenetics Implementation Consortium (CPIC
Blazy C; Ellingrod V; Ward K
Front Pharmacol; 2022; 13():939313. PubMed ID: 35814245
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of pharmacogenomic evidence for drugs related to
Reeves AA; Hopefl R; Deb S
Drug Metab Pers Ther; 2023 Mar; 38(1):65-78. PubMed ID: 36257916
[TBL] [Abstract][Full Text] [Related]
9. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
[TBL] [Abstract][Full Text] [Related]
10. The Clinical Pharmacogenetics Implementation Consortium: 10 Years Later.
Relling MV; Klein TE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Caudle KE
Clin Pharmacol Ther; 2020 Jan; 107(1):171-175. PubMed ID: 31562822
[TBL] [Abstract][Full Text] [Related]
11. PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics.
Hoffman JM; Haidar CE; Wilkinson MR; Crews KR; Baker DK; Kornegay NM; Yang W; Pui CH; Reiss UM; Gaur AH; Howard SC; Evans WE; Broeckel U; Relling MV
Am J Med Genet C Semin Med Genet; 2014 Mar; 166C(1):45-55. PubMed ID: 24619595
[TBL] [Abstract][Full Text] [Related]
12. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update.
Amstutz U; Henricks LM; Offer SM; Barbarino J; Schellens JHM; Swen JJ; Klein TE; McLeod HL; Caudle KE; Diasio RB; Schwab M
Clin Pharmacol Ther; 2018 Feb; 103(2):210-216. PubMed ID: 29152729
[TBL] [Abstract][Full Text] [Related]
13. Developing knowledge resources to support precision medicine: principles from the Clinical Pharmacogenetics Implementation Consortium (CPIC).
Hoffman JM; Dunnenberger HM; Kevin Hicks J; Caudle KE; Whirl Carrillo M; Freimuth RR; Williams MS; Klein TE; Peterson JF
J Am Med Inform Assoc; 2016 Jul; 23(4):796-801. PubMed ID: 27026620
[TBL] [Abstract][Full Text] [Related]
14. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron.
Bell GC; Caudle KE; Whirl-Carrillo M; Gordon RJ; Hikino K; Prows CA; Gaedigk A; Agundez J; Sadhasivam S; Klein TE; Schwab M
Clin Pharmacol Ther; 2017 Aug; 102(2):213-218. PubMed ID: 28002639
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomics Clinical Annotation Tool (PharmCAT).
Sangkuhl K; Whirl-Carrillo M; Whaley RM; Woon M; Lavertu A; Altman RB; Carter L; Verma A; Ritchie MD; Klein TE
Clin Pharmacol Ther; 2020 Jan; 107(1):203-210. PubMed ID: 31306493
[TBL] [Abstract][Full Text] [Related]
16. The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems.
Luzum JA; Pakyz RE; Elsey AR; Haidar CE; Peterson JF; Whirl-Carrillo M; Handelman SK; Palmer K; Pulley JM; Beller M; Schildcrout JS; Field JR; Weitzel KW; Cooper-DeHoff RM; Cavallari LH; O'Donnell PH; Altman RB; Pereira N; Ratain MJ; Roden DM; Embi PJ; Sadee W; Klein TE; Johnson JA; Relling MV; Wang L; Weinshilboum RM; Shuldiner AR; Freimuth RR;
Clin Pharmacol Ther; 2017 Sep; 102(3):502-510. PubMed ID: 28090649
[TBL] [Abstract][Full Text] [Related]
17. Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward.
Caudle KE; Keeling NJ; Klein TE; Whirl-Carrillo M; Pratt VM; Hoffman JM
Pharmacogenomics; 2018 Jul; 19(10):847-860. PubMed ID: 29914287
[TBL] [Abstract][Full Text] [Related]
18. ADME Gene-Related Pharmacogenomic Labeling of FDA-Approved Drugs: Comparison with Clinical Pharmacogenetics Implementation Consortium (CPIC) Evidence Levels.
Deb S; Hopefl R; Reeves AA; Cvetkovic D
Medicines (Basel); 2024 Feb; 11(3):. PubMed ID: 38535119
[TBL] [Abstract][Full Text] [Related]
19. The 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomics.
O'Donnell PH; Bush A; Spitz J; Danahey K; Saner D; Das S; Cox NJ; Ratain MJ
Clin Pharmacol Ther; 2012 Oct; 92(4):446-9. PubMed ID: 22929923
[TBL] [Abstract][Full Text] [Related]
20. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update.
Saito Y; Stamp LK; Caudle KE; Hershfield MS; McDonagh EM; Callaghan JT; Tassaneeyakul W; Mushiroda T; Kamatani N; Goldspiel BR; Phillips EJ; Klein TE; Lee MT;
Clin Pharmacol Ther; 2016 Jan; 99(1):36-7. PubMed ID: 26094938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
